Gut bacteria vs. cancer: probiotic trial aims to stop anal cancer in HIV patients
NCT ID NCT06949800
Summary
This study is testing whether a probiotic supplement can treat anal precancerous lesions and clear the HPV infection that causes them in people living with HIV. The goal is to prevent these lesions from developing into anal cancer. About 90 participants will take either the probiotic or a placebo for 12 weeks, with follow-up checks to see if their lesions shrink or disappear.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV-RELATED SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, San Francisco
San Francisco, California, 94143, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Puerto Rico Comprehensive Cancer Center
San Juan, 00936, Puerto Rico
Contact
Conditions
Explore the condition pages connected to this study.